Delivery Order SPE2DB22D3004-SPE2DB24FPW97
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a pharmaceutical product, BREYNA 160-4.5 MCG INHALER 10.3GM. The contract, valued at $12,438.96, has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a potential value of $1,904.64 and a period of performance through February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This delivery order falls under an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,055.70 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product known as the BREYNA 160-4.5 MCG INHALER 10.3GM. This delivery order contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. AmerisourceBergen Drug Corp is the prime contractor for this contract, which is not designated as a set-aside contract....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.58 firm fixed-price delivery order is for the supply of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM, a medical product, with a ceiling value of $1,151.55 and a period of performance through April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The award is part of Amerisourcebergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 80-4.5 MCG INHALER 10.3GM medication. The delivery order has a firm fixed-price, non-set-aside contract type with a ceiling value of $1,635.99 and a period of performance extending through June 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,279.50 for the supply of BREYNA 80-4.5 MCG INHALER 10.3GM. It is a Firm Fixed Price contract with a period of performance through May 27, 2025. The contract is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.00 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The award is not subject to any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,991.16 order is for the supply of 4,564,257,958 units of the BREYNA 160-4.5 MCG INHALER 10.3GM pharmaceutical product. The contract has an ultimate completion date of April 15, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite...
- This federal contract award, valued at $1,770.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with an ultimate completion date of November 15, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPW97Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of BREYNA 80-4.5 MCG INHALER 10.3GM valued at $1,216.09 with a period of performance through April 8, 2024. This delivery order was placed under an existing indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/5/24 |